Fragment-based drug discovery (FBDD) is one of the most popular approaches for finding lead compounds and it is becoming more widely adopted by pharma companies. FBDD is the solution researchers turn to when faced with challenging targets that call for compound libraries that offer more diverse molecules — especially from new chemical spaces. More importantly, FBDD has shown to improve hit rates and deliver higher-value targets.
NanoTemper has produced an eBook on FBDD.
This eBook will explain:
- The advantages of FBDD over high-throughput screening
- The top biophysical methods used in FBDD
- What the future holds for FBDD